What You Should Know:
– Hurdle (a Chronomics Inc. brand), a global bio-infrastructure platform that powers end-to-end diagnostics for life sciences, labs and healthcare providers, and CloudLIMS, a leading SOC 2 compliant and ISO 9001:2015 certified lab informatics provider, announced today that the companies have entered into a strategic partnership marking the first integration between a Diagnostic as a Service (DaaS) platform and a Software-as-a-Service (SaaS) LIMS provider.
– The partnership brings together Hurdle’s remote diagnostic platform and CloudLIMS’s secure, purpose-built diagnostics LIMS to empower labs with the ability to offer at-home tests, and manage lab processes and data efficiently.
Helping Diagnostic Labs Stay Ahead of the Competition By Extending Remote Diagnostic Testing Services
As a result of this collaboration, Hurdle’s partner labs, such as reference labs and clinical diagnostic labs, will now be able to seamlessly manage lab data, automate workflows, and follow regulatory compliance, such as HIPAA, GDPR, CLIA, ISO 15189:2022.
Many labs today want to offer remote diagnostic services to provide direct-to-patient and direct-to-provider services, saving the time of both patients and providers. Diagnostic labs will now be able to extend their services to patients present in infectious disease hotspots, remote locations, and to underserved communities who are unable to travel to the lab location to get themselves tested. Labs can also improve their offering to existing B2B customers by providing Hurdle’s white-labeled kits.
“Labs using Hurdle are now able to enjoy a completely integrated experience while managing remote diagnostic journeys, which will have a positive impact for all customers,” said Tom Stubbs, co-founder and CEO of Hurdle. “The pandemic highlighted a global need for remote diagnostics while simultaneously exposing a fragmented infrastructure ill-equipped to meet the demand. Today, we’re happy to provide labs with fully integrated and efficient solutions through our dedicated diagnostics infrastructure so that they in turn can continue to support today’s providers and patients.”
